194 results on '"Kuchenbauer F"'
Search Results
2. IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)
3. MicroRNA-155 promotes G-CSF-induced mobilization of murine hematopoietic stem and progenitor cells via propagation of CXCL12 signaling
4. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice
5. RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo
6. P542: REAL WORLD OUTCOMES FOR PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA IN BRITISH COLUMBIA (BC): EXCELLENT OUTCOMES WITH LOW EARLY DEATH RATE AND HIGH OVERALL SURVIVAL IN A POPULATION BASED STUDY
7. Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling
8. Comprehensive microRNA expression profiling of the hematopoietic hierarchy
9. Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia
10. Functional role of BAALC in leukemogenesis
11. The long non-coding RNA Cancer Susceptibility 15 (CASC15) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemia
12. 29-jährige Patientin mit Pneumonie und großen abdominellen Lymphknoten
13. Morbus Teutschländer Eine seltene benigne Differenzialdiagnose proliferativer Raumforderungen im Weichteilgewebe: Eine seltene benigne Differenzialdiagnose proliferativer Raumforderungen im Weichteilgewebe
14. A rare case of acute myeloid leukemia with a CHIC2-ETV6 fusiongen and multiple other molecular aberrations
15. Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETO
16. Expression of the leukemia-associated CALM-AF10 fusion gene in early hematopoietic progenitors causes aggressive bi-phenotypic acute leukemia in transplanted mice: P626
17. Erratum: Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia
18. PS1542 RESPIRATORY SYNCYTIAL VIRUS AND HUMAN METAPNEUMOVIRUS INFECTIONS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: IMPACT OF THE IMMUNODEFICIENCY SCORING INDEX AND RIBAVIRIN TREATMENT ON THE OUTCOMES
19. PF208 MN1 IS INDISPENSABLE FOR MLL-REARRANGED ACUTE MYELOID LEUKEMIA
20. Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
21. Endogenous tumor suppressor microRNA-193b: Therapeutic and prognostic value in acute myeloid leukemia
22. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia
23. Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome
24. Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia
25. The non-coding RNA landscape of human hematopoiesis and leukemia
26. Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia
27. The non-coding RNA landscape of human hematopoiesis and leukemia
28. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice
29. RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo
30. IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)
31. MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia
32. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice
33. Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT
34. MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia
35. Influence of CRBN, IKZF1, and IKZF3 expression on outcome in lenalidomide treated newly diagnosed multiple myeloma patients
36. Charakterisierung KCMF1 defizienter Mauslinien und Analyse der molekularen Funktion von KCMF1
37. Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling
38. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
39. Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia
40. Die potentielle E3-Ubiquitin-Ligase KCMF1 reguliert differentiell die FOXO Transkriptionsfaktoren
41. KCMF1 defiziente Tiere zeigen eine gestörte Erythropoese in der embryonalen Leber
42. IKZF1expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)
43. Functional role of BAALC in leukemogenesis
44. AML1-ETO Needs a Partner: New Insights into the Pathogenesis of t(8;21) Leukemia
45. Regulation of pituitary hormones and cell proliferation by components of the extracellular matrix
46. Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development
47. Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/ AML1-ETO.
48. Extracellular matrix components regulate ACTH production and proliferation in corticotroph tumor cells
49. Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia
50. The role of donor clonal hematopoiesis in allogeneic hematopoietic stem cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.